首页> 外文期刊>Alzheimer s Research & Therapy >Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)
【24h】

Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)

机译:关于脑脊液收集的建议,用于通过ELISA分析神经颗粒性粒蛋白P75,α-突触核蛋白和总tau联合Aβ(1-42)/Aβ(1-40)

获取原文
获取外文期刊封面目录资料

摘要

Background The pathophysiology of neurodegeneration is complex. Its diagnosis requires an early identification of sequential changes in several hallmarks in the brains of affected subjects. The presence of brain pathology can be visualized in the cerebrospinal fluid (CSF) by protein profiling. It is clear that the field of Alzheimer’s disease (AD) will benefit from an integration of algorithms including CSF concentrations of individual proteins, especially as an aid in clinical decision-making or to improve patient enrolment in clinical trials. The protein profiling approach requires standard operating procedures for collection and storage of CSF which must be easy to integrate into a routine clinical lab environment. Our study provides recommendations for analysis of neurogranin trunc P75, α-synuclein, and tau, in combination with the ratio of β-amyloid Aβ(1–42)/Aβ(1–40). Methods Protocols for CSF collection were compared with CSF derived from subjects with normal pressure hydrocephalus ( n =?19). Variables included recipient type (collection, storage), tube volume, and addition of detergents at the time of collection. CSF biomarker analysis was performed with enzyme-linked immunosorbent assays (ELISAs). Data were analyzed with linear repeated measures and mixed effects models. Results Adsorption to recipients is lower for neurogranin trunc P75, α-synuclein, and tau (Conclusions Our study recommends the use of low protein binding tubes for quantification in CSF (without additives) of all relevant CSF biomarkers. Pre-analytical factors have less effect on α-synuclein, neurogranin trunc P75, and total tau, as compared to Aβ(1–42). The ratio of Aβ(1–42)/Aβ(1–40), but not Aβ(1–42)/tau, can be used to adjust for pre-analytical differences in analyte concentrations. Our study does not recommend the inclusion of detergents at the time of collection of CSF. The present results provide an experimental basis for new recommendations for parallel analysis of several proteins using one protocol for collection and storage of CSF.
机译:背景神经变性的病理生理学很复杂。其诊断需要及早识别出受影响受试者大脑中几个标志的顺序变化。脑病理学的存在可以通过蛋白谱分析在脑脊液(CSF)中显示。很明显,阿尔茨海默氏病(AD)领域将受益于包括CSF单个蛋白质浓度在内的算法集成,特别是有助于临床决策或改善患者在临床试验中的人数。蛋白质谱分析方法需要用于收集和储存CSF的标准操作程序,该程序必须易于集成到常规临床实验室环境中。我们的研究为结合β-淀粉样蛋白Aβ(1-42)/Aβ(1-40)的比例提供了分析神经颗粒性粒蛋白P75,α-突触核蛋白和tau的建议。方法比较收集脑脊液的方案和正常脑积水(n = 19)的脑脊液。变量包括接收者类型(收集,存储),试管体积以及收集时添加的清洁剂。使用酶联免疫吸附测定(ELISA)进行CSF生物标志物分析。使用线性重复测量和混合效应模型分析数据。结果神经颗粒蛋白P75,α-突触核蛋白和tau蛋白(受体)的吸附物吸收率较低(结论我们的研究建议使用低蛋白结合管对所有相关CSF生物标记物的CSF(不含添加剂)进行定量分析,分析前因素的影响较小。与Aβ(1-42)相比,α-突触核蛋白,神经颗粒蛋白P75和总tau的变化;Aβ(1-42)/Aβ(1-40)的比率,而非Aβ(1-42)/ tau可用于调整分析物浓度的分析前差异。我们的研究不建议在收集脑脊液时加入去污剂。本研究结果为新的建议提供了实验基础,可以平行分析几种蛋白质CSF收集和存储的协议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号